Underberg Sharon E. sold 6,348 shares of IDEXX LABORATORIES INC DE at $688.25 for −$4.37M on Nov 4, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
EVP, GC & Corporate Secretary
EVP, GC & Corporate Secretary
Filed Nov 5, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$4,368,995.13Shares × reported price
Shares traded
6,348Common Stock
Price per share
$688.25Reported price. Read footnotes for ranges.
% of reported position traded
39.49%This security and ownership context
Holdings after
9,726.654Direct
Trade date
Nov 4, 2026Sell
Filed
Nov 5, 2026, 5:02 PM ET1-day reporting delay
Accession
0000874716-26-000145Code S · Transaction 393717
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 16,074.654 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 4, 2026Sell1,503$689.05−$1,035,636.44Trade 393718
Nov 4, 2026Sell1,055$690.02−$727,973.42Trade 393719
Nov 4, 2026Option exercise8,906$288.78$2,571,874.68Trade 393716
Nov 4, 2026Option exercise8,906——Trade 393720
5 transaction rows in this filing. Joint filers share the same rows.

IDXX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
IDXX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −6.4%1w ago 0%1d ago 0%
Returns since7d +24%30d90d180d1y

Footnotes in full

F1: Includes a total of 31 shares acquired under the Issuer's Employee Stock Purchase Plan on March 31, 2026, June 30, 2026 and September 30, 2026. F2: Represents the weighted average price of the shares sold ranging from a low of $687.70 to a high of $688.67 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F3: Represents the weighted average price of the shares sold ranging from a low of $688.70 to a high of $689.56 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F4: Represents the weighted average price of the shares sold ranging from a low of $690.02 to a high of $690.04 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F5: Grant of option to buy shares of Issuer common stock that vested in four annual installments beginning February 14, 2021. F6: Not applicable.